Specialty medical injectable drug program, requirements and drug policy updates: Skyrizi®

Please review the following table to determine changes to our specialty medical injectable drug programs.

Drug Name UnitedHealthcare Commercial Treatment Uses
X New formulation and dosage, used to treat adults with moderate to severe Crohn’s disease.

Review the UnitedHealthcare Commercial Plan Review at Launch Medication List.

For questions, please contact your broker or UnitedHealthcare representative.

More updates for your clients

New releases, updates and notifications for a broad spectrum of UnitedHealthcare products and services.

Important, required notices for products, plans, forms and more.

Need-to-know operational announcements for you and your clients.